JUBLPHARMA — Jubilant Pharmova Limited

NSE · AI Signal & Stock Analysis · Neutral

As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for JUBLPHARMA is Neutral → (moderate move); technical trend down-trend; trading at ₹950.70 (-3.87% today); neutral (RSI 40).

Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.

Key metrics

What's driving the signal

• Near 52w Low; -Strong Down
• RSI is neutral
• Relative volume 0.11× (light)
• 23% below its 52-week high
• 18% above its 52-week low

Frequently asked about JUBLPHARMA

What is AkshayaAI's signal for JUBLPHARMA today?

As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for JUBLPHARMA (Jubilant Pharmova Limited) is Neutral with a moderate move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.

Is JUBLPHARMA overbought or oversold right now?

JUBLPHARMA's RSI is neutral (RSI 40). A reading above 70 is typically overbought and below 30 oversold.

Where is JUBLPHARMA in its 52-week range?

JUBLPHARMA is trading about 23% below its 52-week high and 18% above its 52-week low as of Aug 14 2026, 6:50 PM.

What is JUBLPHARMA's market capitalisation?

JUBLPHARMA's market capitalisation is ₹13,713 Cr as of Aug 14 2026, 6:50 PM.

What sector is JUBLPHARMA in?

JUBLPHARMA is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.

AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →